Active	Status	Sponsor type	Region	Phase	Filter
2 Active 7 Inactive 9 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
paclitaxel trevatide (ANG1005) / Angiochem
ANGLeD, NCT03613181: ANG1005 in Leptomeningeal Disease From Breast Cancer	Not yet recruiting	3	150	NA	ANG1005, paclitaxel trevatide, Physician's Best Choice, capecitabine, eribulin, high-dose IV methotrexate.	Angiochem Inc	Leptomeningeal Carcinomatosis, Leptomeningeal Metastases, Brain Metastases, HER2-negative Breast Cancer	12/24	12/24
NCT02755987: Expanded Access to ANG1005 for Individual Patients	No Longer Available	N/A		US	ANG1005	Angiochem Inc	Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, Breast Cancer With Recurrent Brain Metastases, Leptomeningeal Carcinomatosis
ANG4043 / Angiochem
No trials found
ANG2002 / Angiochem
No trials found
MPS I enzyme-peptide conjugate / Angiochem
No trials found
ANG1007 / Angiochem
No trials found